Envisagenics is a firm dedicated to the development of healthcare software, which encompasses an artificial intelligence (AI) platform tailored for drug discovery. Envisagenics’ platform leverages RNA sequencing data and AI/ML algorithms to identify, test, and validate drug targets. SpliceCore, their leading platform, is a cloud-based system that has undergone experimental validation for accurately predicting drug targets and biomarkers.
futureTEKnow © 2024 | Miami, FL